Physician profile
Jonathan Jakus
NPI 1033108451
$2,040.88
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $174 · 2021: $312 · 2022: $195 · 2023: $431 · 2024: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $788.21 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $233.29 | 2023-2024 | Myfembree |
| Covidien Lp | $177.61 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $123.80 | 2023 | Exparel |
| Avion Pharmaceuticals | $92.25 | 2019-2022 | |
| Astellas Pharma US INC | $82.11 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $80.31 | 2023-2024 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $61.71 | 2021-2022 | |
| Organon LLC | $55.84 | 2022-2024 | |
| Evofem Biosciences, INC. | $46.25 | 2022-2024 | |
| Exeltis, USA INC. | $43.04 | 2022-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $41.02 | 2019 | |
| Allergan, INC. | $38.50 | 2019 | |
| Daiichi Sankyo INC. | $28.81 | 2019-2020 | |
| Pfizer INC. | $26.39 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $26.08 | 2022 | |
| Biogen, INC. | $24.30 | 2024 | |
| Medtronic, INC. | $23.78 | 2023 | |
| Mayne Pharma Commercial LLC | $16.67 | 2023 | |
| Merck Sharp & Dohme LLC | $16.63 | 2019 | |
| Myovant Sciences INC. | $14.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Jakus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.